<

 
Data updated 2025-06-13 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date16816363.2 (espacenet)  (Federated)  (European Patent Register), 20161216
Patent/reg. no. and dateDK/EP 3390395, 20200909
Publication date20181024
Priority no. and dateGB 201522245, 20151216, GB 201613945, 20160815
EP pub. no. and date EP 3390395 20181024
Effective date
Applicant/ownerLoxo Oncology, Inc., Lilly Corporate Centre
Indianapolis
Indiana 46285, US
Applicant ref. no.V49708DK00
InventorGUISOT, Nicolas, c/o Redx Pharma PLC
Block 33F
Mereside
Alderley Park
Alderley Edge
Cheshire SK10 4TG, GB
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/415 (2006.01) , A61K 31/4155 (2006.01) , A61P 35/00 (2006.01) , C07D 231/14 (2006.01) , C07D 401/04 (2006.01) , C07D 401/06 (2006.01) , C07D 403/04 (2006.01) , C07D 405/04 (2006.01) , C07D 405/06 (2006.01) , C07D 405/08 (2006.01) , C07D 405/14 (2006.01) , C07D 413/06 (2006.01) 
TitleForbindelser, der kan anvendes som kinase-inhibitorer
Int. application no.GB2016053968
Int. publication no.WO2017103611
Related patent (certificate)CA 2024 00006
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact